The impact of the metabolic syndrome on the outcome after aortic valve replacement

Journal of Cardiovascular Medicine

Volumn 15, Issue 10, 2014, Pages 745-751

  Tadic, Marijana ^a   Vukadinovic, Davor ^c   Cvijanovic, Dane ^c   Celic, Vera ^a,d   Kocica, Mladen ^b,d   Putnik, Svetozar ^b,d   Ivanovic, Branislava ^c,d  

^a University Clinical Hospital Center Dragisa Misovic Dedinje   (Serbia)

^b Clinic of Cardiac Surgery   (United States)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

aortic stenosis; diabetes; hypertension; metabolic syndrome; obesity; outcome; valve replacement

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POSTOPERATIVE COMPLICATION; RISK FACTOR; TREATMENT OUTCOME; ANALYSIS; AORTA VALVE; AORTIC VALVE STENOSIS; COMPLICATION; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HEART VALVE PROSTHESIS; HEART VENTRICLE; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BLOOD GLUCOSE; FEMALE; HEART VALVE PROSTHESIS; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; YOUNG ADULT;

EID: 84906938592     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000129     Document Type: Article

References (30)

1. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and metaanalysis of longitudinal studies. J Am Coll Cardiol 2007; 49:403-414.
2. Echahidi N, Pibarot P, Després JP, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007; 50:843-851.
3. Pimenta E, Passarelli O Jr, Borelli F, et al. Metabolic syndrome in patients undergoing coronary artery bypass graft: prevalence and a marker of morbidity/mortality during hospitalization and 30 days after hospital discharge. Arq Bras Cardiol 2007; 88:413-417.
4. Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47:72-75.
5. Katz R, Budoff MJ, Takasu J, et al. Relationship of metabolic syndrome to incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis. Diabetes 2009; 58:813-819.
6. Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006; 47:2229-2237.
7. Pagé A, Dumesnil JG, Clavel MA, et al., ASTRONOMER Investigators. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: A substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol 2010; 55:1867- 1874.
8. Briand M, Pibarot P, Despres JP, et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 2006; 114:I512-I517.
9. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation 2005; 112:2735-2752.
10. American Diabetes Association. Standards of Medical Care in Diabetes - 2009. Diabetes Care 2009; 32 (Suppl 1):S13-S61.
11. Mancia G, De Backer G, Dominiczak A, et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1105-1187.
12. Lang RM, Bierig M, Devereux RB, et al., American Society of Echocardiographys Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108.
13. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20:1251-1260.
14. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
15. Baumgartner H, Hung J, Bermejo J, et al., EAE/ASE. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009; 10:1-25.
16. Rieck A E, Cramariuc D, Boman K, et al. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension 2012; 60:90-97.
17. Capoulade R, Clavel MA, Mathieu P, et al. Impact of hypertension and reninangiotensin system inhibitors in aortic stenosis. Eur J Clin Invest 2013; 43:1262-1272.
18. Orłowska Baranowska E, Abramczuk E, Grabowski M, et al. Factors affecting long-term survival after aortic valve replacement. Kardiol Pol 2012; 70:1120-1129.
19. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high-risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993; 22:1679-1683.
20. Duncan AI, Lowe BS, Garcia MJ, et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 2008; 85:2030-2039.
21. Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi- Ethnic Study of Atherosclerosis. Circulation 2006; 113:2113-2119.
22. Rogge BP, Cramariuc D, Lnnebakken MT, et al. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: A SEAS Substudy (Simvastatin Ezetimibe in Aortic Stenosis). J Am Coll Cardiol 2013; 62:1683-1690.
23. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611-617.
24. Roberts WC, Roberts CC, Vowels TJ, et al. Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass grafting. Am J Cardiol 2011; 108:1767-1771.
25. Dumesnil JG, Pibarot P. The obesity paradox in aortic stenosis: to be or not to be. J Am Coll Cardiol 2013; 62:1691-1693.
26. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009; 53:577-584.
27. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2:367-373.
28. Capoulade R, Clavel MA, Dumesnil JG, et al., TRONOMER Investigators. Insulin resistance and LVH progression in patients with calcific aortic stenosis: A substudy of the ASTRONOMER trial. JACC Cardiovasc Imaging 2013; 6:165-174.
29. Canepa M, Strait JB, Milaneschi Y, et al. The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. Nutr Metab Cardiovasc Dis 2013; 23:1263-1270.
30. de las Fuentes L, Waggoner AD, Brown AL, Dávila-Román VG. Plasma triglyceride level is an independent predictor of altered left ventricular relaxation. J Am Soc Echocardiogr 2005; 18:1285-1291.